Who are Garlic powder standardized to allicin's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Kava.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/garlic-powder-standardized-to-allicin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Garlic powder standardized to allicin — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Garlic powder standardized to allicin (Garlic powder standardized to allicin) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal supplement / botanical extract. Area: Cardiovascular / Immunology / Infectious disease.

phase 3 Herbal supplement / botanical extract Cardiovascular / Immunology / Infectious disease Small molecule Live · refreshed every 30 min

Target snapshot

Garlic powder standardized to allicin (Garlic powder standardized to allicin) — National Center for Complementary and Integrative Health (NCCIH). Allicin, the active compound in garlic powder, exerts antimicrobial, anti-inflammatory, and antioxidant effects through multiple cellular pathways.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Garlic powder standardized to allicin TARGET	Garlic powder standardized to allicin	National Center for Complementary and Integrative Health (NCCIH)	phase 3	Herbal supplement / botanical extract
Kava	Kava	Masonic Cancer Center, University of Minnesota	marketed	Herbal supplement / botanical extract

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal supplement / botanical extract class)

Masonic Cancer Center, University of Minnesota · 1 drug in this class
National Center for Complementary and Integrative Health (NCCIH) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Garlic powder standardized to allicin — Competitive Intelligence Brief. https://druglandscape.com/ci/garlic-powder-standardized-to-allicin. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab